戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 elopment for the treatment of hepatitis C or myocardial reperfusion injury.
2 ibution of nondiabetic and diabetic blood to myocardial reperfusion injury.
3 ity resulting in increased cytoprotection in myocardial reperfusion injury.
4 he protective functional phenotype of MIF in myocardial reperfusion injury.
5 uld prevent neutrophil activation and reduce myocardial reperfusion injury.
6 ming may not utilize ADO's potential against myocardial reperfusion injury.
7 ma has been shown to be cardioprotective for myocardial reperfusion injury and ischemia and may play
8  itself induce cardiomyocyte death, known as myocardial reperfusion injury, for which there is still
9 currently under investigation for preventing myocardial reperfusion injury have the potential to impr
10  associated with oxidative stress, including myocardial reperfusion injury, heart transplantation, st
11 l and antithrombotic properties that reduces myocardial reperfusion injury in animal models of myocar
12 itric oxide bioavailability, and ameliorated myocardial reperfusion injury in the setting of severe h
13 dings suggest that the blood contribution to myocardial reperfusion injury is amplified in diabetes.
14                                              Myocardial reperfusion injury is associated with the inf
15                                              Myocardial reperfusion injury is mediated in part by acc

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。